TC

Timothy C. Dec

Senior Vice President, Chief Financial Officer

Supernus Pharmaceuticals

Roles

Senior Vice President, Chief Financial OfficeratSupernus Pharmaceuticals
Chief Financial OfficeratOpGen

Supernus Pharmaceuticals Pipeline

DrugIndicationPhase
Qelbree® (viloxazine ER)Attention-Deficit/Hyperactivity Disorder (ADHD)Approved/Commercial
Trokendi XR®Epilepsy, Migraine PreventionApproved/Commercial
Oxtellar XR®EpilepsyApproved/Commercial
SPN-820/821Treatment-Resistant Depression (TRD)Phase 2
SPN-817Severe EpilepsyPhase 2
Adderall XR®ADHDApproved/Commercial
Intuniv®ADHDApproved/Commercial
Mydayis®ADHDApproved/Commercial